Guideline Profile : Rheumatoid arthritis
You are here : Home > Formulary Search > Guideline Profile : Rheumatoid arthritis
Documentation
Guidelines (National)
Drugs
Below are listed all drugs that are used to treat Rheumatoid arthritis.
Committee Recommendations (1)
The Surrey Heartland Integrated Care System Area Prescribing Committee have agreed the SERMOG Rheumatoid Arthritis high-cost drugs pathway.
Guideline Profile
Indication :
Rheumatoid arthritis
Keywords :
Abatacept, adalimumab, etanercept, anakinra, baricitinib, certolizumab, golimumab, infliximab, rituximab, tocilizumab, sarilumab, tofacitinib, upadacitinib, filgotinib, penicillamine, prednisone, sodium aurothiomalate, RA, Immunomodulator, Protein Kinase Inhibitor, JAK inhibitor, Janus Kinase, NICE TA, JAKI, anti-TNF, TNF alpha, b-cell, IL 6, interleukin inhibitor, biosimilar, biologic, SERMOG, RA-ILD
Brand Names Include :
MabThera, Truxima, Rixathon, Ruzience, Orencia, Humira, Hyrimoz, Imraldi, Amgevita, Hulio, Yuflyma, Idacio, Kineret, Olumiant, Cimzia, Enbrel, Benepali, Erelzi, Jyseleca, Simponi, Remicade, Inflectra, Remsima, Flixabi, Zessly, Distamine, Lodotra, Kevzara, Myocrisin, RoActemRA, Tyenne, Xeljanz, Rinvoq, Ituxredi
Important Information :
Latest Additions Date From :
Latest Additions Date To :
Supporting Documents :
3